Abstract
We encountered a patient with previously well-controlled Wilson disease who experienced fulminant hepatic failure with hemolytic anemia, possibly caused by the dietary supplement Health Proportion® (Jubilant Co., Ltd., Ehime, Japan). A 21-year-old woman was admitted to our hospital with marked liver dysfunction and severe hemolytic anemia. Free serum copper level was elevated at 101 μg/dl, and urinary copper excretion was extremely increased (25,600 μg/day). Plasma exchange and continuous hemodiafiltration were performed to remove serum copper and to treat the hemolytic anemia. However, liver function did not improve, and she underwent liver transplantation on 28th day after admission. Copper and iron contents in the resected liver were high at 851.9 μg and 551.7 μg/dry liver weight (g), respectively, despite the patient having regularly taken d-penicillamine since diagnosis and having a well-controlled copper level 1 year before her admission. Two months before admission, the patient had taken a dietary supplement made from soybeans for 1 month. This supplement was labeled as containing large amounts of copper and iron, and we assume that this caused fulminant hepatic failure with hemolytic crisis in this patient. It is important to be mindful of the micronutrient content of dietary supplements, especially for metabolic disorder patients.
Similar content being viewed by others
References
Wilson SAK. Progressive lenticular degeneration: a familial nervous disease associated with cirrhosis of the liver. Brain. 1912;34:295–507.
Kusuda Y, Hamaguchi K, Mori T. Novel mutations of the ATP7B gene in Japanese patients with Wilson disease. J Hum Genet. 2000;45:86–91.
Ferenci P, Członkowska A, Merle U, Ferenc S, Gromadzka G, Yurdaydin C, et al. Late-onset Wilson’s disease. Gastroenterology. 2007;132:1294–8.
Roberts EA, Schilsky ML. A practice guideline on Wilson disease. Hepatology. 2003;37:1475–92.
Frydman M. Genetic aspects of Wilson’s disease. J Gastroenterol Hepatol. 1990;5:483–90.
Thomas GR, Forbes JR, Roberts EA. The Wilson disease gene: spectrum of mutations and their consequences. Nat Genet. 1995;9:210–7.
McIntyre N, Clink HM, Levi AJ. Hemolytic anemia in Wilson’s disease. New Engl J Med. 1967;276:439–44.
Shiono Y, Kumasawa S, Hayashi H. Iron accumulation in the liver of male patients with Wilson’s disease. Am J Gastroenterol. 2001;96:3147–51.
Rakela J, Kurtz SB, McCarthy JT. Fulminant Wilson’s disease treated with postdilution hemodiafiltration and orthotopic liver transplantation. Gastroenterology. 1986;90:2004–7.
Sarles J, Lefevre P, Picon G. Plasma exchange for fulminant Wilson disease. Eur J Pediatr. 1992;151:310.
Kiss JE, Berman D, Van Thiel D. Effective removal of copper by plasma exchange in fulminant Wilson disease. Transfusion. 1998;38:327–31.
Nagata Y, Uto H, Hasuike S, Ido A, Hayashi K, Eto T, et al. Bridging use of plasma exchange and continuous hemodiafiltration before living donor liver transplantation for acute fulminant Wilson disease. Intern Med J. 2003;42:967–70.
Shinno H, Sugita Y, Wada M. Foods with health claims. Shokuseikatsu. 2004;98:47–52.
Ogimoto M, Uematsu Y, Kabashima J, Suzuki K, Yasuno T, Kohmaru Y, et al. Determination of mineral contents in commercial mineral supplements, vol 57. Tokyo: Annual report of Tokyo Metropolitan Institute of Public Health; 2006. p. 267–71.
Dietary reference intakes for Japanese. Tokyo: Ministry of Health, Labour, and Welfare, Japan; 2005.
Turnlund JR. Human whole-body copper metabolism. Am J Clin Nutr. 1998;67(suppl):960S–4S.
Walshe JM, Yealland M. Chelation treatment of neurological Wilson’s disease. Q J Med. 1993;86:197.
Watanabe M, Shibuya A. Validity study of a new diagnostic scale for drug-induced liver injury in Japan—comparison with two previous scales. Hepatol Res. 2004;30:148–54.
Maria VA, Victorino RM. Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis. Hepatology. 1997;26:664–9.
Wai CT, Tan BH, Chan CL, Sutedja DS, Lee YM, Khor C, et al. Drug-induced liver injury at an Asian center: a prospective study. Liver Int. 2007;27:465–74.
Whitt KN, Ward SC, Deniz K, Liu L, Odin JA, Qin L. Cholestatic liver injury associated with whey protein and creatine supplements. Semin Liver Dis. 2008;28:226–31.
Kawata K, Takehira Y, Kobayashi Y, Kitagawa M, Yamada M, Hanajima K, et al. Three cases of liver injury caused by Sennomotokounou, a Chinese dietary supplement for weight loss. Intern Med. 2003;42:1188–92.
Sanchez W, Maple JT, Burgart LJ, Kamath PS. Severe hepatotoxicity associated with use of a dietary supplement containing usnic acid. Mayo Clin Proc. 2006;81:541–4.
Koga H, Taguchi J, Ishii K, Inoue K, Sato K, Sanefuji T. A survival case of fulminant hepatic failure caused by Chinese diet medicine (in Japanese with English abstract). Kanzo. 2003;44:117–22.
Food composition database (Internet). Japan Science and Technology Agency (updated 2005 May 31). Available from: http://fooddb.jp/.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kawai, K., Atarashi, Y., Takahara, T. et al. Dietary supplement implicated in fulminant hepatic failure in a well-controlled Wilson disease patient. Clin J Gastroenterol 2, 119–124 (2009). https://doi.org/10.1007/s12328-008-0056-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12328-008-0056-6